Lab-Grown Diamond Margin Gains, Raised Guidance Reshape Signet Jewelers' Outlook

Signet Jewelers’ fiscal second quarter delivered a tidy 3 percent year‑over‑year sales increase, a beat that prompted management to raise guidance and helped send the stock up 2.74 percent after the report. Executives and analysts point to a rapid expansion of lab‑grown diamonds in fashion assortments, a higher average transaction value in fashion of 12 percent, and tighter discounting as the near‑term engines of margin improvement.

Analysts have gone further, linking a meaningful portion of Signet’s margin expansion to higher gross margins on lab‑grown diamonds. Simply Wall St put that case bluntly: "To own Signet today, you have to believe its mix shift toward higher margin lab grown diamonds, stronger omnichannel presence, and tighter inventory can offset structural headwinds in bridal and fashion jewelry demand." Simply Wall St’s model projects Signet could reach $7.0 billion in revenue and $612.3 million in earnings by 2028, valuing the stock at $113.38 per share, about an 18 percent upside from current levels; that path, the firm notes, assumes roughly a 1.0 percent annual revenue decline from today and an earnings climb from $130.4 million to about $612.3 million.

Company commentary and analyst summaries offer slightly different measures of lab‑grown penetration: a LinkedIn summary and JCKonline quoted executive remarks that lab‑grown share in fashion doubled from 7 percent to 14 percent in the quarter, while Simply Wall St reported lab‑grown diamonds at about 15 percent of fashion sales and even put a figure of 40 percent of bridal sales under lab‑grown coverage. Management has emphasized that lab‑grown acts as a "category extender" for fashion, with Signet expanding inventory below $1,000 and concentrating on the $250–$500 and $500–$1,000 bands to lift reach and average transaction value.

The company’s executives framed price and sourcing dynamics as equally consequential. J.K. Symancyk, Signet CEO, said, "The customer that is buying something like a lab‑grown diamond tennis bracelet...is not a core traditionalist that is choosing between a natural diamond or a lab‑grown diamond." In a JCKonline Q&A, Hilson detailed supply responses to tariffs: "Our team has done a great job managing the tariff situation. India represents roughly 50% of our finished jewelry purchases. We’ve worked with our vendors to negotiate specific SKU pricing for critical items for the holidays, and we have tried to get as much product in early before the tariffs are incurred. We are also working with our vendors to explore opportunities to shift production to other countries from India. We would expect some benefit within our merchandise margin, but the timing and the amount is still very uncertain."

Tariffs have risen—JCKonline noted a 50 percent rate on Indian goods—and Signet has been shifting production, negotiating SKU pricing and front‑loading imports, while offering fewer and narrower discounts. The company says bridal remains a consistent performer and that retail prices for lab‑grown have stabilized even as some natural diamond prices edged up over the prior six months.

Risks remain acute. Portersfiveforce analysis lists demand cyclicality, lab‑grown price deflation, competitive intensity from digital natives and luxury houses, supply‑chain and sourcing shocks, and execution risk around omnichannel integration as potential brakes on progress. For Signet, the question moving forward is clear: can a mix tilted toward higher‑margin lab‑grown fashion, tighter inventory and omnichannel gains sustain raised guidance if bridal unit demand softens or tariffs and sourcing shifts bite into merchandise margin.